All In MedTech

FDA Clearance Tracker · P990064-S094

Mosaic Neo Mitral Bioprosthesis

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 3, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 3, 2026

Approved

Time to decision

180 days

Received Sep 4, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990064-S094
Device name
Mosaic Neo Mitral Bioprosthesis
Applicant location
Santa Ana, CA
Received
Sep 4, 2025
Decided
Mar 3, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P990064

Device type

Device class
Class III
Regulation
21 CFR 870.3925

Every decision under product code DYE

FDA's approval statement

As written in FDA's record.

approval for updates to the sewing cuff, suture markings, radiopaque marker, holder, and sizers.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.